List of works - Tania Jones

Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.

scientific article published in June 2009

BORIS/CTCFL is an RNA-binding protein that associates with polysomes.

scientific article

CTCF binds to sites in the major histocompatibility complex that are rapidly reconfigured in response to interferon-gamma

scientific article published on 25 February 2012

Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastoma

scientific article published on 21 October 2021

DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas.

scientific article published on 27 May 2016

Enzymatic degradation of RNA causes widespread protein aggregation in cell and tissue lysates

scientific article published on 18 September 2020

Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation.

scientific article published on 11 August 2016

Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2

scientific article (publication date: 8 March 2002)

Identification of a subset of trace amine-associated receptors and ligands as potential modulators of insulin secretion

scientific article published on 01 November 2019

Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways

scientific article

Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development

scientific article

P-STAT1 mediates higher-order chromatin remodelling of the human MHC in response to IFNgamma

scientific article published on 28 August 2007

RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology

scientific article published on 10 March 2011

Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complex

scientific article published on 10 October 2008

Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome

scientific article

Widespread expression of BORIS/CTCFL in normal and cancer cells

scientific article

List of works by Tania Jones

Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.

BORIS/CTCFL is an RNA-binding protein that associates with polysomes.

CTCF binds to sites in the major histocompatibility complex that are rapidly reconfigured in response to interferon-gamma

Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastoma

DNA methylation analysis of paediatric low-grade astrocytomas identifies a tumour-specific hypomethylation signature in pilocytic astrocytomas.

Enzymatic degradation of RNA causes widespread protein aggregation in cell and tissue lysates

Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation.

Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2

Identification of a subset of trace amine-associated receptors and ligands as potential modulators of insulin secretion

Molecular analysis of pediatric brain tumors identifies microRNAs in pilocytic astrocytomas that target the MAPK and NF-κB pathways

Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development

P-STAT1 mediates higher-order chromatin remodelling of the human MHC in response to IFNgamma

RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology

Reconfiguration of genomic anchors upon transcriptional activation of the human major histocompatibility complex

Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome

Widespread expression of BORIS/CTCFL in normal and cancer cells